Similar Papers

Paper Title
Journal
Date
Author
Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma.
Lixin Zhang ... Sebastian Manegold
Molecular Therapy | VOL. 6
Lixin Zhang, et. al.Lixin Zhang ... Sebastian Manegold
01 Sep 2002
The role of the receptor tyrosine kinase-like orphan receptors (RORs) in human breast cancer
Saskia Heinrichs
-
Saskia HeinrichsSaskia Heinrichs
05 Dec 2022
Abstract 3444: Identification of Interleukin-1 (IL-1) induced gene expression pattern in breast cancer (BCa) cells
Afshan Fathima Nawas ... Mohammed Kanchwala
Cancer Research | VOL. 79
Afshan Fathima Nawas, et. al.Afshan Fathima Nawas ... Mohammed Kanchwala
01 Jul 2019
P0229 Possible interaction between HIF-1α and VGSCS in aggressive breast cancer cells
H.D Dewadas ... N.F Mokhtar
European Journal of Cancer | VOL. 50
H.D Dewadas, et. al.H.D Dewadas ... N.F Mokhtar
01 May 2014
View more papers

More From: Cancer Biology & Therapy

Paper Title
Journal
Date
Author
NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia
Qing Zhu ... Peifang Xiao
Cancer Biology & Therapy | VOL. 26
Qing Zhu, et. al.Qing Zhu ... Peifang Xiao
12 Jan 2025
The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway
Cheng Zhong ... Eiichi Gohda
Cancer Biology & Therapy | VOL. 25
Cheng Zhong, et. al.Cheng Zhong ... Eiichi Gohda
31 Dec 2025
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer
Celina Ablinger ... Petra Huber-Cantonati
Cancer Biology & Therapy | VOL. 25
Celina Ablinger, et. al.Celina Ablinger ... Petra Huber-Cantonati
31 Dec 2025
Targeting autophagy promotes the antitumor effect of radiotherapy on cervical cancer cells
Fanjie Meng ... Huiying Yu
Cancer Biology & Therapy | VOL. 25
Fanjie Meng, et. al.Fanjie Meng ... Huiying Yu
31 Dec 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.